{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:18:50Z","timestamp":1792718330220,"version":"4.5.0"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Focal myositis is a rare, localized, benign, self-limiting, and non-suppurative inflammatory lesion of the skeletal muscle that may occasionally occur as a complication of rheumatic diseases. This case report discusses a 58-year-old patient with rheumatoid arthritis, who was diagnosed with focal myositis during standard immunosuppressive therapy. The patient was treated with tofacitinib; to our knowledge, this is the first reported case of focal myositis managed with this medication. Clinicians should maintain a suspicion for focal myositis in patients presenting with localized muscle swelling and pain, especially those with underlying rheumatic conditions. In cases where corticosteroid tapering proves difficult, tofacitinib may be considered as an alternative therapeutic strategy.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1502410","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T06:39:51Z","timestamp":1735022391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["An effective strategy with tofacitinib for the management of focal myositis with rheumatoid arthritis: a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Jing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"B1","article-title":"Focal myositis: a localized form of polymyositis","volume":"20","author":"Flaisler","year":"1993","journal-title":"J Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4598(200010)23:10<1569::AID-MUS14>3.0.CO;2-M","article-title":"Clinical and pathologic features of focal myositis","volume":"23","author":"Smith","year":"2000","journal-title":"Muscle Nerve"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270703","article-title":"Rheumatoid myositis. Clinical and histologic features and possible pathogenesis","volume":"27","author":"Halla","year":"1984","journal-title":"Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.658907","article-title":"A patient with focal myositis and primary cutaneous diffuse large B-cell lymphoma: A case report","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"bcr1220103574","DOI":"10.1136\/bcr.12.2010.3574","article-title":"Focal myositis of the thigh misdiagnosed radiologically as rhabdomyosarcoma","volume":"2011","author":"Binesh","year":"2011","journal-title":"BMJ Case Rep"},{"key":"B6","first-page":"631","article-title":"Focal myositis: a review of 100 previously published cases and a report of 2 new cases","volume":"17","author":"Yanmaz Alnigenis","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000255773.15356.34","article-title":"Localized striated muscle vasculitis in rheumatoid arthritis","volume":"13","author":"Ali","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e12900","DOI":"10.1111\/nan.12900","article-title":"Occurrence of focal myositis during Beh\u00e7et\u2019s disease: The identification of a specific vasculitis-associated focal myopathy","volume":"49","author":"Gallay","year":"2023","journal-title":"Neuropathol Appl Neurobio"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08786-6","article-title":"JAK inhibitors: prospects in connective tissue diseases","volume":"59","author":"You","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00018-024-05196-1","article-title":"Macrophage re-programming by JAK inhibitors relies on MAFB","volume":"81","author":"L\u00f3pez-Navarro","year":"2024","journal-title":"Cell Mol Life Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1502410\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T06:39:52Z","timestamp":1735022392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1502410\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":10,"alternative-id":["10.3389\/fimmu.2024.1502410"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1502410","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"article-number":"1502410"}}